Page last updated: 2024-10-25

ciprofloxacin and Tuberculosis, Hepatic

ciprofloxacin has been researched along with Tuberculosis, Hepatic in 2 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Tuberculosis, Hepatic: Infection of the LIVER with species of MYCOBACTERIUM, most often MYCOBACTERIUM TUBERCULOSIS. It is characterized by localized small tuberculous miliary lesions or tumor-like mass (TUBERCULOMA), and abnormalities in liver function tests.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Valerga, M1
Cugliari, M1
Cefalo, E1
Martín, M1
Trauner, M1
Grasmug, E1
Stauber, RE1
Hammer, HF1
Hoefler, G1
Reisinger, EC1

Other Studies

2 other studies available for ciprofloxacin and Tuberculosis, Hepatic

ArticleYear
[Mycobacterium avium infection in a renal transplant recipient].
    Enfermedades infecciosas y microbiologia clinica, 2007, Volume: 25, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Biopsy; Ciprofloxacin; Clarithromycin; Diagnosi

2007
Recurrent Salmonella enteritidis sepsis and hepatic tuberculosis.
    Gut, 1995, Volume: 37, Issue:1

    Topics: Adult; Anti-Infective Agents; Bacteremia; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistanc

1995